ConductScience.org, home
IL1R2: interleukin 1 receptor type 2
API referenceFor AI assistants

Gene · 7850

Papers2,718

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

1 to 20 of 2,718

Download this page as JSON
TitleJournalYearPMIDFound bySource
IL-1R2+ neutrophils define an early sterile injury-expanded subset that restrains inflammation and promotes repair.JCI Insight202642771477PubTator, text miningPubMed
Targeted proteomics reveal histiocytosis-associated neurodegeneration signatures.Hemasphere202642707979PubTator, text miningPubMed
A Decoy-Receptor-Armed Biomimetic Nanotherapeutic With Inherent Tropism for Conserved Pathogenic Macrophages for Treating Osteoarthritis and Intervertebral Disc Degeneration.Adv Sci (Weinh)202642621674PubTator, text miningPubMed
Integrated Bioinformatics Analysis Identifies FCER1G, IL1R2, and BST1 as Diagnostic Biomarkers and Therapeutic Targets in Sepsis.J Clin Lab Anal202642590911PubTator, text miningPubMed
IL1R2⁺ Inflammatory Monocytes Contribute to Immune Dysregulation and Predict Mortality in COVID-19.Shock202642580331PubTator, text miningPubMed
Machine learning identifies neutrophil-related signatures for diagnostic value in neonatal sepsis.J Clin Biochem Nutr202642524644PubTator, text miningPubMed
Circulating immune profiling reveals impaired monocyte states and trajectories driving immunosuppression in glioblastoma.J Neuroinflammation202642464264PubTator, text miningPubMed
Systems-level insights into bronchopulmonary dysplasia from meta-analysis of genome-scale studies.Respir Res202642458458PubTator, text miningPubMed
IL1R2 identified as a key hub gene regulating vascular endothelial function in Kawasaki disease.Sci Rep202642373790PubTator, text miningPubMed
Blood transcriptomic endotyping of COPD identifies a neutrophil-driven inflammatory endotype reflected by the neutrophil-to-lymphocyte ratio.Respir Res202642351125PubTator, text miningPubMed
Oxidative Stress Induced Senescent Macrophage-Driven Squamous Cell Carcinoma Invasion via Glutamine Metabolic Reprogramming.Aging Cell202642333921PubTator, text miningPubMed
Deciphering the Heterogeneous Microenvironment of Head and Neck Squamous Cell Carcinoma Through an Integrated Immune Inflammation Framework.Int J Genomics202642326763PubTator, text miningPubMed
Unveiling a ceRNA Network Involving IL-8 and TNF-α in Active Generalized Vitiligo by Multi-Omics Integration.Immunotargets Ther202642281618PubTator, text miningPubMed
Granulocyte heterogeneity in immune-mediated and inflammatory diseases: insights from single-cell transcriptomic analyses.Int Immunol202642186818PubTator, text miningPubMed
Distinct molecular profile in Sjögren's syndrome is associated with disease activity and clinical manifestations.Sci Rep202642185429PubTator, text miningPubMed
[Interleukin-1 activity regulators in acute decompensated heart failure: dependence on obesity degree].Ter Arkh202642107125PubTator, text miningPubMed
A Tertiary Lymphoid Structure-Derived Prognostic Signature Integrates Immune Microenvironment and Mutational Landscapes in Clear Cell Renal Cell Carcinoma.Hum Mutat202642058673PubTator, text miningPubMed
Unveiling the prognostic and immunotherapeutic role of Tregs in lung cancer using integrated analysis of single-cell and bulk RNA-sequencing.Oncol Lett202642038348PubTator, text miningPubMed
Development of a Panel of Molecular Biomarkers of Asthma: Analysis of Differential Expression and Stability Over Time.J Investig Allergol Clin Immunol202641885088PubTator, text miningPubMed
Phase II study of olaparib and durvalumab in patients with metastatic castration-resistant prostate cancer.J Immunother Cancer202641881502PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Next page

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/7850/papers

API referenceFor AI assistants